HU900094D0 - Process for production of heparin fractions having anti-hiv activity - Google Patents

Process for production of heparin fractions having anti-hiv activity

Info

Publication number
HU900094D0
HU900094D0 HU9094A HU9490A HU900094D0 HU 900094 D0 HU900094 D0 HU 900094D0 HU 9094 A HU9094 A HU 9094A HU 9490 A HU9490 A HU 9490A HU 900094 D0 HU900094 D0 HU 900094D0
Authority
HU
Hungary
Prior art keywords
production
hiv activity
heparin fractions
heparin
sulfated polysaccharides
Prior art date
Application number
HU9094A
Other languages
English (en)
Other versions
HU203373B (en
HUT53129A (en
Inventor
Alan Douglas Cardin
Richard Lee Jackson
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of HU900094D0 publication Critical patent/HU900094D0/hu
Publication of HUT53129A publication Critical patent/HUT53129A/hu
Publication of HU203373B publication Critical patent/HU203373B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU9094A 1989-01-11 1990-01-10 Process for producing heparin having anti-hiv activity HU203373B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29585689A 1989-01-11 1989-01-11
US37579589A 1989-07-05 1989-07-05

Publications (3)

Publication Number Publication Date
HU900094D0 true HU900094D0 (en) 1990-03-28
HUT53129A HUT53129A (en) 1990-09-28
HU203373B HU203373B (en) 1991-07-29

Family

ID=26969370

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9094A HU203373B (en) 1989-01-11 1990-01-10 Process for producing heparin having anti-hiv activity

Country Status (11)

Country Link
EP (1) EP0406512B1 (hu)
JP (1) JPH02263801A (hu)
KR (1) KR0159774B1 (hu)
AT (1) ATE90566T1 (hu)
CA (1) CA2007258A1 (hu)
DE (1) DE69001957T2 (hu)
DK (1) DK0406512T3 (hu)
ES (1) ES2058606T3 (hu)
HU (1) HU203373B (hu)
IE (1) IE63167B1 (hu)
IL (1) IL93003A0 (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5456924A (en) * 1988-12-23 1995-10-10 Immunotec Research Corporation Ltd. Method of treatment of HIV-seropositive individuals with dietary whey proteins
JP3615785B2 (ja) * 1994-04-28 2005-02-02 テルモ株式会社 Ｈｉｖ及びその関連物質除去材料
ITMI20011633A1 (it) * 2001-07-27 2003-01-27 San Raffaele Centro Fond Uso di polisaccaridi batterici supersolfatati inibitori dell'hiv

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4119774A (en) * 1976-03-05 1978-10-10 Ab Kabi Heparin purification method
EP0292663B1 (en) * 1987-05-25 1995-06-14 Research Development Corporation Of Japan A method for producing vitronectin
EP0293826A3 (en) * 1987-06-02 1989-05-10 Stichting REGA V.Z.W. Therapeutic and prophylactic application of sulfated polysaccharides against aids

Also Published As

Publication number Publication date
CA2007258A1 (en) 1990-07-11
EP0406512A1 (en) 1991-01-09
HU203373B (en) 1991-07-29
IE900083L (en) 1990-07-11
HUT53129A (en) 1990-09-28
DK0406512T3 (da) 1993-08-09
JPH02263801A (ja) 1990-10-26
KR900011788A (ko) 1990-08-02
IL93003A0 (en) 1990-09-17
EP0406512B1 (en) 1993-06-16
KR0159774B1 (ko) 1998-11-16
DE69001957T2 (de) 1993-09-23
ATE90566T1 (de) 1993-07-15
DE69001957D1 (de) 1993-07-22
IE63167B1 (en) 1995-03-22
ES2058606T3 (es) 1994-11-01

Similar Documents

Publication Publication Date Title
SE7407445L (hu)
ZA839652B (en) Process for the depolymerisation and sulfation of polysaccharides
IL86881A0 (en) Polysaccharides extractred from plants,their preparation and pharmaceutical compositions containing them
EP0265865A3 (en) Blood substitute
ATE131176T1 (de) Sulfatierte polysaccharide, antikoagulierungs- und antikomplementärmittel, hergestellt aus fukanen aus braunen algen, und verfahren zu deren herstellung.
ATE40555T1 (de) Verfahren zur organischen synthese von oligosacchariden,welche galactosamin- und uronsaeure-motive umfassen, oligosaccharide und ihre biologischen verwendungen.
NL191308C (nl) Gelyofiliseerd, na oplossing injecteerbaar preparaat dat een antracycline-glycoside bevat, alsmede werkwijze voor de bereiding van een injecteerbare oplossing van een antracycline-glycoside.
KR940027658A (ko) 트롬빈 결합성 물질 및 이의 제조방법
HU900094D0 (en) Process for production of heparin fractions having anti-hiv activity
KR890002228A (ko) 태반조직 단백질 pp 4의 정제방법
DE69530689D1 (de) Heparin-binding protein zur behandlung von sepsis
FI853095L (fi) Foerfarande foer aotervinning av en gelbildande polysackarid, aotervunnen polysackarid och gel bildad daermed.
EP0361490A3 (en) Sulfated oligosaccharides and derivatives thereof
HU905943D0 (en) Process for producing anti-coagulant and anti-helmintic proteins and their utilization
SE8403929D0 (sv) Recombinant dna molecule, transformed microorganisms and process for producing penicillin v amidase
Mazzini et al. Affinity chromatography on concanavalin A-Sepharose of antigenic fractions of human seminal plasma
IT8722631A0 (it) Derivati proteici del ferro altamente biodisponibile e tollerabili, loro preparazione e composizioni farmaceutiche che licontengono.
ES8200701A1 (es) Procedimiento de disminuir el contenido de fenilalanina de los hidrolizados de proteinas y similares
Hahiri et al. Applications of high-performance liquid chromatography to the characterization of the interactions of heparin with antithrombin III and thrombin
GB9001593D0 (en) Thiophilic absorbents
KR920000917A (ko) 재조합 인체 종양괴사인자(TNF-α)의 정제방법
LaFrance et al. End point attached heparin affinity matrix
KR910009727A (ko) 리포코르틴의 정제방법
IT8620463A0 (it) Procedimento di purificazione di eparine, frazioni e frammenti eparinici.

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee